~191 spots leftby Apr 2026

Embolic Protection Devices for Preventing Embolism

(ProtectH2H Trial)

Recruiting in Palo Alto (17 mi)
+1 other location
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Emboline
No Placebo Group
Prior Safety Data

Trial Summary

What is the purpose of this trial?

Prospective, randomized, open label, multicenter, 2-arm, safety and efficacy study

Eligibility Criteria

This trial is for adults over 18 with symptomatic severe aortic stenosis eligible for TAVR valve treatment. Participants must consent to follow-up and not have conditions like unicuspid aortic valve, recent heart attack or stroke, severe allergies to specific medications, bleeding disorders, certain mental health issues, or be pregnant.

Inclusion Criteria

I am 18 years old or older.
Willing to participate in study and provide signed EC/IRB-approved informed consent
I have agreed to undergo a TAVR procedure.
See 2 more

Exclusion Criteria

I do not have dementia or any cognitive issues that prevent me from understanding or following study instructions.
Unable or unwilling to complete all required screening and/or follow-up assessments, including subjects with active major psychiatric disease; with severe visual, auditory, or learning impairment
I am not planning any heart surgery around the time of my TAVR procedure.
See 26 more

Treatment Details

Interventions

  • Emboliner Embolic Protection (Embolization Device)
  • Sentinel Cerebral Protection (Embolization Device)
Trial OverviewThe study compares two devices designed to protect the brain from embolism during TAVR: Emboliner Embolic Protection vs. Sentinel Cerebral Protection. It's an open-label trial where patients are randomly assigned to one of the two arms to assess safety and effectiveness.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Emboliner Embolic Protection DeviceExperimental Treatment1 Intervention
Emboliner embolic protection device to be used during TAVR procedures for stroke prevention
Group II: Sentinel Cerebral Protection SystemActive Control1 Intervention
Sentinel Cerebral Protection System to be used during TAVR procedures for stroke prevention

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
NewYork-Presbyterian/Columbia University Medical CenterNew York, NY
Oklahoma Heart InstituteTulsa, OK
Loading ...

Who Is Running the Clinical Trial?

EmbolineLead Sponsor

References